Molecular pathways and therapeutic targets in lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Lung cancer is a leading global cause of cancer mortality.
• Significant histological and molecular heterogeneity exists within lung cancer subtypes.
• Understanding molecular alterations is crucial for effective treatment strategies.

Purpose of the Study:

• To review current knowledge on molecular pathways in lung cancer.
• To emphasize clinical implications of actionable molecular targets.
• To discuss targeted and immune therapies for lung cancer treatment.

Main Methods:

• Literature review of current research on lung cancer pathways.
• Analysis of molecular alterations in non-small cell lung cancer (adenocarcinoma, squamous cell carcinoma) and small cell carcinoma.
• Summary of approved and investigational targeted and immune therapies.

Main Results:

• Detailed description of major molecular pathways and alterations driving lung cancer.
• Identification of specific molecular blueprints for different lung cancer types.
• Overview of clinical trial landscape for targeted lung cancer therapies.

Conclusions:

• Molecularly targeted therapies and immunotherapies offer promising treatment avenues.
• Personalized treatment approaches based on specific molecular alterations are advancing lung cancer care.
• Continued research into molecular targets is essential for improving patient outcomes.